Trials / Conditions / Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
3 registered clinical trials studyying Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal C NCT03575234 | Emory University | Phase 1 |
| Active Not Recruiting | Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squ NCT03799445 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | New Modalities for Detection of Oropharyngeal Cancer NCT03226613 | Vanderbilt University Medical Center | N/A |